BioCentury
ARTICLE | Clinical News

Aurexis: Phase II data

May 16, 2005 7:00 AM UTC

In a double-blind, placebo-controlled, U.S. Phase II trial in 60 patients, Aurexis plus standard antibiotic therapy led to 1 death and 1 infection relapse vs. 4 deaths with antibiotic therapy plus pla...